Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Correlation analysis showed that Dg(18:4(6Z,9Z,12Z,15Z)/18:1(11Z)/0:0), Dg(9D3/9M5/0:0), and 25-Hydroxycholecalciferol were negatively correlated with metabolites associated with cardiovascular protection, neuroregulation, and hormonal effects.

Source: Metabolomic analysis of colonic content and its correlation with gut microbiota. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Animal research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Male C57BL/6J wild-type and LDLR−/− mice were fed either a normal diet (ND) or HCD for 12 weeks, with gut microbiota profiled at weeks 0, 8, and 12.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Temporal gut microbiota dysbiosis links metabolic impairment, LDL desialylation, and accelerated atherosclerosis in LDLR−/− mice

Study design awaiting verification · Frontiers in Medicine · 2026

Original publication title

Temporal gut microbiota dysbiosis links metabolic impairment, LDL desialylation, and accelerated atherosclerosis in LDLR−/− mice

Guoying Guan; Wei Zhang; Yingying Zhuang; Jia Sheng; Siyi Wang; Nishang Zheng; Xinyue Wang; Hongwei Li; Yuhong Wang

Copyright © 2026 Guan, Zhang, Zhuang, Sheng, Wang, Zheng, Wang, Li and Wang.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: What background does the paper provide?

This study used low-density lipoprotein receptor-deficient (LDLR−/−) mice fed a high-cholesterol diet (HCD) to establish an accelerated atherosclerosis model and to characterize the temporal dynamics of gut microbiota remodeling during disease progression.

Source: Introduction

Abstract: What methods does the paper describe?

Male C57BL/6J wild-type and LDLR−/− mice were fed either a normal diet (ND) or HCD for 12 weeks, with gut microbiota profiled at weeks 0, 8, and 12. HCD markedly accelerated atherogenesis in genetically susceptible mice, as evidenced by increased body weight, visceral adiposity, aggravated atherosclerotic lesions, and dyslipidemia.

Source: Methods

Abstract: Discussion

HCD promotes atherosclerosis progression in the context of LDLR deficiency by inducing time-dependent gut microbiota dysbiosis, characterized by structural reorganization and progressive functional impairment. This dysbiotic trajectory promotes pathogenic metabolite accumulation, systemic inflammatory activation, and LDL desialylation through a microbiota-metabolism-immune axis. These findings provide mechanistic insight into the gut microbial regulation of atherosclerosis and support the development of microecology-based strategies for cardiovascular disease prevention and intervention.

Source: Discussion

Abstract: Results

Time-resolved microbiota analysis revealed progressive community reorganization, characterized by expansion of Bacillota and Actinomycetota and depletion of Bacteroidota, with the most pronounced alterations observed in the HCD group. These microbial shifts were closely associated with reduced sialic acid content on LDL particles, suggesting a potential link between gut microbial dysbiosis and LDL desialylation. Functional profiling further showed a dynamic transition in microbial metabolic capacity. At week 8, the HCD group exhibited a compensatory enhancement of selected metabolic pathways, whereas by week 12, broad functional deterioration emerged, involving energy metabolism, cellular structural biosynthesis, and genetic information-processing pathways.

These findings indicate a progressive loss of microbial functional resilience under sustained high-cholesterol exposure. Metabolomic analysis revealed suppression of cholesterol metabolism and bile acid biosynthesis pathways, activation of insulin resistance-related signaling, and accumulation of candidate pathogenic metabolites, including specific diglycerides and 25-hydroxycholecalciferol. These metabolites were associated with enhanced inflammatory activation and reduced LDL sialylation, suggesting that diet-induced microbial and metabolic perturbations may converge to amplify systemic chronic inflammation and accelerate atherogenesis.

Source: Results
Authors’ abstract

Introduction

This study used low-density lipoprotein receptor-deficient (LDLR−/−) mice fed a high-cholesterol diet (HCD) to establish an accelerated atherosclerosis model and to characterize the temporal dynamics of gut microbiota remodeling during disease progression.

Methods

Male C57BL/6J wild-type and LDLR−/− mice were fed either a normal diet (ND) or HCD for 12 weeks, with gut microbiota profiled at weeks 0, 8, and 12. HCD markedly accelerated atherogenesis in genetically susceptible mice, as evidenced by increased body weight, visceral adiposity, aggravated atherosclerotic lesions, and dyslipidemia.

Results

Time-resolved microbiota analysis revealed progressive community reorganization, characterized by expansion of Bacillota and Actinomycetota and depletion of Bacteroidota, with the most pronounced alterations observed in the HCD group. These microbial shifts were closely associated with reduced sialic acid content on LDL particles, suggesting a potential link between gut microbial dysbiosis and LDL desialylation. Functional profiling further showed a dynamic transition in microbial metabolic capacity. At week 8, the HCD group exhibited a compensatory enhancement of selected metabolic pathways, whereas by week 12, broad functional deterioration emerged, involving energy metabolism, cellular structural biosynthesis, and genetic information-processing pathways.

These findings indicate a progressive loss of microbial functional resilience under sustained high-cholesterol exposure. Metabolomic analysis revealed suppression of cholesterol metabolism and bile acid biosynthesis pathways, activation of insulin resistance-related signaling, and accumulation of candidate pathogenic metabolites, including specific diglycerides and 25-hydroxycholecalciferol. These metabolites were associated with enhanced inflammatory activation and reduced LDL sialylation, suggesting that diet-induced microbial and metabolic perturbations may converge to amplify systemic chronic inflammation and accelerate atherogenesis.

Discussion

HCD promotes atherosclerosis progression in the context of LDLR deficiency by inducing time-dependent gut microbiota dysbiosis, characterized by structural reorganization and progressive functional impairment. This dysbiotic trajectory promotes pathogenic metabolite accumulation, systemic inflammatory activation, and LDL desialylation through a microbiota-metabolism-immune axis. These findings provide mechanistic insight into the gut microbial regulation of atherosclerosis and support the development of microecology-based strategies for cardiovascular disease prevention and intervention.

Publication and source details

Original title: Temporal gut microbiota dysbiosis links metabolic impairment, LDL desialylation, and accelerated atherosclerosis in LDLR−/− mice

Guoying Guan; Wei Zhang; Yingying Zhuang; Jia Sheng; Siyi Wang; Nishang Zheng; Xinyue Wang; Hongwei Li; Yuhong Wang

Frontiers in Medicine · 2026

* Correspondence: Yuhong Wang, Dr.yuhongwang@gmail.com; Hongwei Li, rocque@xmu.edu.cn; Xinyue Wang, wang.xinyue@zsxmhospital.comCopyright © 2026 Guan, Zhang, Zhuang, Sheng, Wang, Zheng, Wang, Li and Wang.2026Guan, Zhang, Zhuang, Sheng, Wang, Zheng, Wang, Li and Wanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the Scientific Novelty Fund of the First Affiliated Hospital of Harbin Medical University (Grant No. 2023M01).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:11:44.312284+00:00

DOI: 10.3389/fmed.2026.1754833 · PMC13372019